Log In
Print this Print this

levotofisopam (S-tofisopam)

  Manage Alerts
Collapse Summary General Information
Company Pharmos Corp.
DescriptionS-entantiomer of racemic tofisopam
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationHyperuricemia / gout
Indication DetailsTreat hyperuricemia and gout
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today